InnoPharmax, Inc. will participate in CPHI 2026, to be held in Milan, Italy from October 6 to October 8, 2026, and will exhibit at the Taiwan Pavilion organized by the Industrial Technology Research Institute (ITRI).
   CPHI is one of the key global platforms for the pharmaceutical industry, bringing together companies and professionals across APIs, formulation development, drug delivery technologies, clinical development, licensing, and pharmaceutical supply chains. The 2025 exhibition drew participants from more than 166 countries, with over 60,000 attendees and 2,900 exhibitors registered, underscoring its role as a major international meeting point for the pharmaceutical industry.
   Through this event, InnoPharmax looks forward to reconnecting with long-term partners and engaging with potential collaborators to explore opportunities in licensing, co-development, clinical development collaboration, and regional market expansion.
   During the exhibition, InnoPharmax will introduce its development pipeline, finished products, the global Phase 3 clinical trial of GemOral®, and the potential application of its proprietary oral drug delivery platform, OralPAS®, in the co-development of candidate products.
   We sincerely welcome industry partners and professionals to visit the InnoPharmax team at Booth 8F2 in the Taiwan Pavilion during the exhibition.
   
   Event Information
   Event: CPHI 2026
   Date: October 6 to October 8, 2026
   Venue: Fiera Milano, Milan, Italy
   Booth: Taiwan Pavilion｜Booth 8F2
   LinkedIn: https://www.linkedin.com/feed/update/urn:li:activity:7499008093545062400